A Promising New Anti-Cancer Strategy: Iron Chelators Targeting CSCs.

Chen, Yuehua; Ohara, Toshiaki; Xing, Boyi; Qi, Jiping; Noma, Kazuhiro; Matsukawa, Akihiro

Chen, Yuehua; Ohara, Toshiaki; Xing, Boyi; Qi, Jiping; Noma, Kazuhiro; Matsukawa, Akihiro.

Afiliación

Chen Y; Department of Pathology and Experimental Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Ohara T; Department of Pathology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
Xing B; Department of Pathology and Experimental Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Qi J; Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Noma K; Department of Pathology and Experimental Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Matsukawa A; Department of Pathology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.

Acta Med Okayama ; 74(1): 1-6, 2020 Feb.

Article en En | MEDLINE | ID: mdl-32099242

Asunto(s)

Antineoplásicos/uso terapéutico; Quelantes del Hierro/uso terapéutico; Hierro/metabolismo; Neoplasias/tratamiento farmacológico; Antineoplásicos/farmacología; Humanos; Quelantes del Hierro/farmacología; Células Madre Neoplásicas/efectos de los fármacos

Palabras clave

cancer stem cell; chelation; chemotherapy; iron; stemness

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Quelantes del Hierro / Hierro / Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: Acta Med Okayama Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google